Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi · 2012
Extrahepatic complications of chronic cholestasis: current diagnosis and treatment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Prelipcean Cristina Cijevschi, Mihai Cătălina, Gogălniceanu P, Mihai B
Аннотация
Pruritus, fatigue and osteoporosis are the main symptoms of the extra hepatic manifestations of chronic cholestasis that affect patients' quality of life. Pruritus affects more often female patients, varies as intensity during a day and for longer period of time, typically can be localized on the palms of hands and soles of feet or can be generalized. Pruritus can be treated with anions resines exchange--cholestiramine, the pregnanne X receptor agonist Rifampicine, Naltrexone. Liver transplantation can be considered if severe pruritus remains refractory to all medical treatments. Fatigue is the most disabling complain in chronic colestasis. No specific therapies are available for fatigue and liver transplantation doesn't improve it. Osteoporosis and the risk of fractures are more severe with the duration and severity of hepatic disease. For treatment are recommended regular physical exercise, vitamin D and Ca supplimentation and bisphosphonates (Alendronate 70 mg/week) in severe cases. Only patients with atherosclerotic risk and hyperlipemia can be treated with statines. Fat soluble vitamin supplementation can be administrated only in symptomatic and proved vitamin deficiency.
Предметные рубрики MeSH
AntipruriticsBone Density Conservation AgentsCalciumCholestasisCholestasis, ExtrahepaticCholestasis, IntrahepaticChronic DiseaseDrug Therapy, CombinationExerciseFatigueFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLiver TransplantationMaleOsteoporosisPruritusQuality of LifeRisk FactorsSex FactorsTreatment OutcomeVitamin D